TBCRC 035 UAB 15114: Palbociclib in Combination with Fulvestrant or Tamoxifen as Treatment for Hormone Receptor Positive Metastatic Breast Cancer with Prior Chemotherapy for Advanced Disease: A Phase II Study with Pharmacodynamics Markers (TBCRC 35)
October 19, 2016 - August 29, 2018
Johns Hopkins University
Total Award Amount
Sponsor Award Id
Erica Stringer-Reasor M.D.